bumetanide
Commercial- Indications
- Edema
Company intelligence / Profile preview
Edenbridge Pharmaceuticals
Parsippany, New Jersey, United Statesedenbridgepharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Edenbridge Pharmaceuticals specializes in developing and marketing both branded and generic prescription drugs. The company has commercialized several products including DARTISLA ODT for peptic ulcer disease, Hemady for multiple myeloma, Yargesa for Gaucher disease, as well as generic bumetanide and ivermectin tablets. It maintains a robust pipeline with a focus on limited-source generics and specialty products using advanced delivery technologies like Zydis orally disintegrating tablets. In June of 2022 it was acquired by Dexcel Pharma. As of October 2024 it operates under the name "Dexcel Pharma USA".
- Therapeutic areas
- OncologyRare DiseasesGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeTablet (oral solid dose)Orally disintegrating tablet
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Catalent for Zydis formulation/manufacturing of glycopyrrolate/DARTISLA ODTOrsini Specialty Pharmacy for Yargesa distribution
Beyond the preview
Go deeper on Edenbridge Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Edenbridge Pharmaceuticals.